
    
      A multi-regional clinical trial with participating sites planned in the following countries
      pending approval from the applicable oversight authorities:

        -  Argentina

        -  Brazil

        -  Bulgaria

        -  Canada

        -  Colombia

        -  Czech Republic

        -  Denmark

        -  France

        -  Germany

        -  Hungary

        -  India

        -  Israel

        -  Japan

        -  Mexico

        -  Netherlands

        -  Poland

        -  Romania

        -  Russian Federation

        -  Slovakia

        -  South Africa

        -  Spain

        -  Ukraine

        -  United Kingdom

        -  United States
    
  